Life Science Software Market to Grow by USD 3.97 billion from 2022 to 2027, Progressing at a CAGR of 8.1% - Technavio

NEW YORK, Feb. 8, 2024 /PRNewswire/ -- The global life science software market size is estimated to grow by USD 3.97 billion from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 8.1% during the forecast period. North America held the largest share of the global market in 2022, and the market in the region is estimated to witness an incremental growth of 49%. 

For more insights on the historical data (2017 to 2021) and forecast size (2023 to 2027) - Request a sample report

Technavio has segmented the market based on End-user (Pharmaceutical, Biotechnology, and Others), Deployment (Cloud-based and On-premise), and Geography (North America, Europe, APAC, South America, and Middle East and Africa). 

• The pharmaceutical segment is significant during the forecast period. Life science software offers a global healthcare standard, which can benefit pharmaceutical companies and enhance existing ERP systems, augments the capabilities of logistic partners, and facilitates collaboration with trading partners such as contract packagers. Such software increases company visibility, aids in analytics, and provides risk management. Furthermore, pharmaceutical companies can leverage these solutions throughout the product lifecycle to reduce time-to-market, accelerate research and drug discovery, and streamline commercial operations for revenue growth. Additionally, life sciences software also enables advanced analytics for clinical, sensor, and other Big Data, supporting personalized medicine and the development of innovative drugs and medical devices.

By geography, the global life science software market is segmented into North America, Europe, APAC, South America, and Middle East and Africa. The report provides actionable insights and estimates the contribution of all regions to the growth of the global life science software market.

• North America will contribute 49% to the growth during the forecast period.

Insights on the contribution of various segments including country and region, historical data (2017 to 2021), and forecast size (2023 to 2027) - Download a Sample Report

Significant growth is driven by the imperative to enhance operational efficiency. These software solutions streamline data collection and management, optimize performance, and facilitate decision-making processes. Cloud-based supply chain management solutions further improve inventory management and support recalls efficiently, offering automated alerts and recommendations. Such benefits propel market expansion as enterprises seek to remain competitive and compliant amidst evolving industry demands.

• The growing demand for SaaS-based life science software is an emerging trend fueling the growth, however, the frequent changes in mandates hamper the growth.

Insights on Drivers, trends, & Challenges, historic period(2017 to 2021), and forecast period(2023 to 2027)- Request a sample report!

What are the key data covered in this Life Science Software Market report?

• CAGR during the forecast period
• Detailed information on factors that will drive the growth of the Life Science Software Market between 2023 and 2027
• Precise estimation of the Life Science Software Market size and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the Life Science Software industry across North America, Europe, APAC, South America, and Middle East and Africa
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of Life Science Software vendors

Technavio's SUBSCRIPTION platform

Applications

The Life Science Software industry offers diverse solutions like Bioinformatics, LIMS, and Genomics software, catering to drug discovery, clinical trials, and healthcare analytics. Key segments include EHR, CTMS, and molecular modeling software, enhancing research and regulatory compliance. Advanced technologies like NGS and precision medicine software drive innovation, while digital pathology and healthcare analytics address population health management needs. Regulatory compliance and biomarker discovery remain critical considerations in this dynamic market.

Related Reports:

The contract life-cycle management (CLM) software market is estimated to grow at a CAGR of 18.8% between 2022 and 2027. The size is forecast to increase by USD 2,922.58 million.

The industrial automation market in the life sciences industry market is forecast to increase by USD 5.06 billion with a CAGR of 11.4% between 2023 and 2028.

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging trends and provide actionable insights to help businesses identify opportunities and develop effective strategies to optimize their positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable insights to identify opportunities in existing and potential markets and assess their competitive positions within changing scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio